×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Assessment of Impact and Effectiveness of Risk Management and Minimization in the EU and US
Session Chair(s)
Saad Shakir, DrMed, MD, FFPM, FISPE, FRCP
Director
Drug Safety Research Unit, United Kingdom
Impacts of Safety Warning and Risk Evaluation and Mitigation Strategies on Drug Utilization and Clinical Outcome
Learning Objective : Discuss methods used to assess the impact and effectiveness of risk management and minimization methods; Identify the application of some of the tools used to examine the effectiveness of risk management and minimization.
Speaker(s)
Evaluating Risk Evaluation and Mitigation Strategies Effectiveness Using Existing Tools
Annette Stemhagen, DrPH, PhD, FISPE
UBC, United States
Chief Science Officer
Impacts of Safety Warning and Risk Evaluation and Mitigation Strategies on Drug Utilization and Clinical Outcome
Jason C. Hsu
National Cheng Kung University, Taiwan
Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences
Monitoring and Studying the Effectiveness of Risk Management and Minimization in the EU
Saad Shakir, DrMed, MD, FFPM, FISPE, FRCP
Drug Safety Research Unit, United Kingdom
Director
Have an account?